期刊文献+

基质金属蛋白酶-2及基质金属蛋白酶抑制剂-2在子宫内膜异位症中的表达及分析

Expression of MMP-2 and TIMP-2 in endometriosis
暂未订购
导出
摘要 目的通过检测组织中基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶抑制剂-2(TI MP-2)的表达,探讨它们在子宫内膜异位症发生、发展中的作用。方法用原位杂交染色技术对MMP-2和TI MP-2mRNA进行测定。结果①MMP-2在异位内膜的表达高于在位内膜(P<0·05);在位内膜MMP-2的表达显著强于正常子宫内膜(P<0·05),而且异位组中Ⅲ、Ⅳ期组与Ⅰ、Ⅱ期组间差异有统计学意义(P<0·05)。TI MP-2在位内膜的表达低于正常子宫内膜(P<0·05),异位内膜中TI MP-2的表达显著低于在位内膜(P<0·05),而且异位组中Ⅲ、Ⅳ期组与Ⅰ、Ⅱ期组间差异有统计学意义(P<0·05)。②在正常内膜中,MMP-2与TI MP-2之间呈负相关,r=-0·710。结论患者组织中MMP-2和TI MP-2的异常表达在子宫内膜异位症的发生、发展中起重要的作用。 Objective To investigate the expression of MMP-2 and TIMP-2 in affected tissue from women with and without endometriosis for exploring the role of MMP-2 and TIMP-2 in endometriosis. Methods Expression of MMP-2 and TIMP-2 mRNA was evaluated by in situ hybridization. Results ①Both ectopic and entopic endometrium expressed higher levels of MMP-2 and lower levels of TIMP-2 than endometrium from normal women. Also, ectopic endometrium expressed higher levels of MMP-2 and lower level of TIMP-2 than entopic endometrium from endometriosis patients. The higher levels of MMP-2 and the lower levels of TIMP-2 expressed in stages Ⅲ/Ⅳ than in stages Ⅰ/Ⅱ. ②There was a significantly negative correlation between expression of MMP-2 and TIMP-2 in normal endometrium. Conclusion MMP-2 and TIMP-2 play an important role in the progression of endometriosis.
机构地区 山西医科大学
出处 《山西医药杂志》 CAS 2006年第3期202-203,T0001,共3页 Shanxi Medical Journal
关键词 子宫内膜异位症 基质金属蛋白酶-2 金属蛋白酶2组织抑制剂 Endometriosis Gelatinase A Tissue inhibitor of metalloproteinase-2
  • 相关文献

参考文献4

  • 1齐璇.基质金属蛋白酶及其抑制物与子宫内膜异位症[J].国外医学(妇幼保健分册),2002,13(1):14-16. 被引量:10
  • 2Nsolle M,Casanas-Roux F,Anaf V,et al.Morphometric study of the stromal vascularization in peritoneal endometriosis.Fertil Steril,1993,59(3):681-684.
  • 3Sharpe Timms KL,Zimmer RL,Jolliff WJ,et al.Gonadotropin-releasing hormone agonist(GnRH-a) therapy alters activity of plasminogen activators,matrix metalloproteinases,and their inhibitors in rat models for adhesion formation and endometriosis:potential GnGH-a-regulated mechanisms reducing adhesion formation.Fertil Steril,1998,69(5):916-923.
  • 4Osteen KG,Bruner-Tran KL,Keller NR,et al.Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment:a regulatory system altered in endometriosis.Ann NY Acad Sci,2002,955:37-47.

二级参考文献11

  • 1Gottschalk C,Malberg K,Amdt M,et al.Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis[J].Adv Exp Med Biol,2000,477:483-486.
  • 2Garbett EA,Reed MW,Brown NJ,et al.Proteolysis in human breast and colorectalcancer[J] .Br J Cancer,1999,81(2) :287 293.
  • 3Bruner Tran KL,Rier SE,Eisenberg E,et al.The potential role of environmental toxins in the pathophysiology of endometriosis[J].Gynecol Obstet Invest,1999,48(Suppl 1 ) :45-56.
  • 4Kokorine I,Eckhout Y,Nisole M,et al.Expression of interstirial collngenase(matrix metalloproteinase-1 ) is related to the activity of human endometriotic lesions[J].Fertil Steril,1997,68 (2):246-251.
  • 5Bruner KL,Matrisian LM,Rodgers WH,et al.Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in mice[J] .J Clin Invest,1997,99(12):2851-2857.
  • 6Bruner KL,Matrisian LM,Rodgers WH.Suppression of matrix metalloproteinases inhibits establishmem of ectopic lesions by human endometrium in nude mice[J].J Clin Invest,1997,99 ( 12):2851-2857.
  • 7Kim I,Kim HG,Moon SO,et al.Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion[J].Circ Res ,2000,86 (9): 952 959.
  • 8Sharpe Timms KL,Zimmer RL,Jolliff WJ,et al.Gonadotropin -releasing hormone agonist(GnRH-a) therapy alters activity of plasminogen activators,matrix metalloproteinases,and their inhibitors in rat models for adhesion formation and endometriosis:potential GnRH-a -regulated mechanisms reducing adhesion formation[J].Fertil Steril,1998,69(5) :916-923.
  • 9Osteen KG,Keller NR,Feltus FA,et al.Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium[J] .Gynecol Obstet Invest,1999,48(Suppl 1)2-13.
  • 10Steward WP.Marimastat(BB2516):current status of developement[J] .Cancer Chemother Pharmacol,1999,43(Suppl) :S 56--60.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部